Nevertheless, having confirmed the anti-colitic effect of the M(IL4)s used here, the murine M(IL4) was found to reduce the severity of inflammation induced by C. rodentium, suggesting that susceptibility to bacterial infection need not be a significant side effect of M(IL4) therapy. Here, IL4 is linked to bacterial infectious disease.